FP
DXCM icon

Foundry Partners’s DexCom DXCM Stock Holding History

Foundry Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,173
Closed -$440K – 298
2024
Q1 		$440K Hold
3,173
– – 0.02% 230
2023
Q4 		$394K Hold
3,173
– – 0.02% 241
2023
Q3 		$296K Sell
3,173
-1,312
-29% -$148K 0.02% 259
2023
Q2 		$576K Hold
4,485
– – 0.04% 233
2023
Q1 		$521K Sell
4,485
-67
-1% -$7.5K 0.03% 236
2022
Q4 		$515K Buy
+4,552
New +$500K 0.03% 228

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Foundry Partners's DXCM Position: Q2 2024 in Review

Foundry Partners sold out of DexCom (DXCM) in Q2 2024, closing a stake of 3,173 shares — an estimated $440K sold.

Foundry Partners first reported a position in DXCM in Q4 2022 and held it in 6 quarters. The position peaked at $576K in Q2 2023. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Foundry Partners reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Foundry Partners sold 3,173 DexCom shares in Q2 2024, an estimated $440K.
  • Foundry Partners first reported a position in DexCom in Q4 2022 and held it in 6 quarters.
  • Foundry Partners's DexCom position peaked at $576K in Q2 2023.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Foundry Partners's 13F filing for Q2 2024, filed 5 Aug 2024.